Suppr超能文献

调节性T细胞分化和功能的先天性缺陷。

Inborn errors of regulatory T-cell differentiation and function.

作者信息

Oktelik Fatma Betul, Luo Ying, Benamar Mehdi, Chatila Talal A

机构信息

Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass; Department of Immunology, Aziz Sancar Institute of Experimental Medicine (Aziz Sancar DETAE), Istanbul University, Istanbul, Turkey.

Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Rheumatology and Immunology, Shenzhen Children's Hospital, Shenzhen, China.

出版信息

J Allergy Clin Immunol. 2025 Jul 7. doi: 10.1016/j.jaci.2025.07.001.

Abstract

Regulatory T (Treg) cells play an essential role in enforcing peripheral immune tolerance and promoting tissue homeostasis and repair. Our understanding of their pivotal role in immune regulation has critically benefited from the identification of a growing number of inborn errors of immunity known as Tregopathies, which target different pathways governing Treg cell biology. The resulting disorders associated with mutations in gene such as FOXP3, CTLA4, IL2RA, IL2RB, BACH2, IKAROS, STAT3, LRBA, and DEF6 manifest both unique and overlapping phenotypes of immune dysregulation and autoimmunity, highlighting the distinctive roles of individual Treg cell pathways targeted by inborn errors of immunity in immune regulation. We examine the current knowledge of Tregopathies and the immune regulatory networks they affect.

摘要

调节性T(Treg)细胞在维持外周免疫耐受、促进组织稳态和修复方面发挥着至关重要的作用。我们对其在免疫调节中关键作用的理解,极大地受益于越来越多被称为Treg细胞病的先天性免疫缺陷的发现,这些缺陷靶向控制Treg细胞生物学的不同途径。与FOXP3、CTLA4、IL2RA、IL2RB、BACH2、IKAROS、STAT3、LRBA和DEF6等基因的突变相关的疾病,表现出免疫失调和自身免疫的独特且重叠的表型,突出了免疫先天性缺陷所靶向的各个Treg细胞途径在免疫调节中的独特作用。我们研究了目前关于Treg细胞病及其所影响的免疫调节网络的知识。

相似文献

1
Inborn errors of regulatory T-cell differentiation and function.
J Allergy Clin Immunol. 2025 Jul 7. doi: 10.1016/j.jaci.2025.07.001.
2
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency.
J Allergy Clin Immunol. 2018 Dec;142(6):1679-1695. doi: 10.1016/j.jaci.2018.10.026.
4
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
5
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.
J Allergy Clin Immunol. 2017 Feb;139(2):607-620.e15. doi: 10.1016/j.jaci.2016.03.059. Epub 2016 Jun 18.

本文引用的文献

1
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy.
Cell Rep. 2024 Nov 26;43(11):114938. doi: 10.1016/j.celrep.2024.114938. Epub 2024 Nov 2.
4
A patient-based murine model recapitulates human STAT3 gain-of-function syndrome.
Clin Immunol. 2024 Sep;266:110312. doi: 10.1016/j.clim.2024.110312. Epub 2024 Jul 15.
6
Adipose-tissue Treg cells restrain differentiation of stromal adipocyte precursors to promote insulin sensitivity and metabolic homeostasis.
Immunity. 2024 Jun 11;57(6):1345-1359.e5. doi: 10.1016/j.immuni.2024.04.002. Epub 2024 Apr 30.
7
Treg-tissue cell interactions in repair and regeneration.
J Exp Med. 2024 Jun 3;221(6). doi: 10.1084/jem.20231244. Epub 2024 Apr 26.
8
mTOR-mediated differentiation and maintenance of suppressive T cells at the center stage of IPEX treatment.
Immunol Res. 2024 Aug;72(4):523-525. doi: 10.1007/s12026-024-09472-x. Epub 2024 Mar 11.
9
Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation.
J Allergy Clin Immunol. 2024 Jul;154(1):229-236.e2. doi: 10.1016/j.jaci.2024.01.029. Epub 2024 Mar 2.
10
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models.
J Clin Invest. 2024 Mar 1;134(5):e173107. doi: 10.1172/JCI173107.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验